Research Peptides
Tesamorelin
Stabilised GRF(1-44) analogue for GHRH receptor studies.
Tesamorelin is a stabilised analogue of growth-hormone releasing hormone (GRF 1-44) carrying a trans-3-hexenoyl N-terminal modification. It is supplied as a reference standard for in-vitro GHRH receptor research.
Select a size
Line total
$62.00
Dispatched cold in insulated packaging within 48 hours.
Specifications
- Purity
- ≥98% (HPLC)
- Form
- Lyophilized powder
- Sequence
- trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
- Molecular weight
- 5135.90 Da
- CAS number
- 218949-48-5
- Storage
- Store at -20°C, protected from light
Specifications are listed for reference. Always confirm against the certificate of analysis supplied with your lot.
Research use only
This material is supplied for in-vitro laboratory research and analytical study only. It is not for human or veterinary use, not a medicine, supplement or cosmetic, and must never be ingested, injected or applied to any living organism. Purchasers must be 21 or over and qualified to handle research chemicals safely.
Research & literature
What published research reports
The following summarises peer-reviewed literature for scientific reference only. AethelBio products are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary use, diagnosis, prevention, or treatment of any condition.
Proposed mechanism
A stabilised analogue of growth-hormone-releasing hormone (GHRH 1-44) that stimulates endogenous pulsatile GH and IGF-1 secretion.
Reported areas of research
Studied for reducing visceral adipose tissue in HIV-associated lipodystrophy, with additional research on body composition and cognitive endpoints.
PubMed references
Verified buyer reviews
What researchers say
No reviews yet — be the first to share your results.